Parlokast
5 mg
Montelukast Sodium
Segment 06 · Anti-asthmatic Agents
Parlokast5 mg
Montelukast Sodium
Parlokast
5 mg
Montelukast Sodium
Leukotriene receptor antagonist for asthma and allergic rhinitis.
Export fast-track. DRAP export registration in about a month for products developed against export orders. Describe the formulation
- Generic composition
- Montelukast Sodium
- Strength
- 5 mg
- Dosage form
- Chewable Tablets
- Pack sizes
- 14's
Other forms & strengths of Parlokast
- Manufacturer
- Paramount Pharmaceuticals, Islamabad
- Licence
- DML 000439 · DRAP GMP
- Release
- Batch-tested, with Certificate of Analysis
For healthcare professionals. Registration status, brand names and pack presentations vary by market. Experienced a side effect? Report it here.
Parlokast
How it's made
Tablets are made by granulation and compression, then coated where the product calls for it. Made in the general production section.
How all our dosage forms are made →- 01
Dispensing
Each raw material is released by QC, then weighed for the batch under a second person's check.
- 02
Granulation
The active ingredient and excipients are mixed and granulated so the powder flows and compresses evenly.
- 03
Drying and sizing
Granules are dried to a set moisture limit and milled to a uniform size.
- 04
Blending
Lubricant is added and the blend is mixed until the active ingredient is evenly spread through it.
- 05
Compression
The press forms each tablet to a set weight, hardness and thickness, checked at intervals through the run.
- 06
Coating
Coated tablets receive a film or sugar coat in a coating pan; uncoated and chewable tablets skip this step.
- 07
Packing
Tablets are sealed into blister strips, which are coded with the batch number and expiry date.
Batch release tests
- Uniformity of weight
- Hardness and friability
- Disintegration
- Dissolution
- Assay of the active ingredient
- Microbial limits
Limits for this product are on each batch's Certificate of Analysis.
